Morbi et tellus imperdiet, aliquam nulla sed, dapibus erat. Aenean dapibus sem non purus venenatis vulputate. Donec accumsan eleifend blandit. Nullam auctor ligula

Get In Touch

Quick Email
info.help@gmail.com
  • Home |
  • FDA plans to release more drug rejection letters as controversial policy resumes

FDA plans to release more drug rejection letters as controversial policy resumes

  • July 14, 2026

After pausing a controversial policy to publicly release drug rejection letters in April, the FDA today confirmed that the pause has been lifted and that more documents will be coming down the line.

Leave A Comment

Fields (*) Mark are Required